A regulation included in the US Food and Drug Administration’s cosmetics program overhaul to standardize and require testing for asbestos in talc-containing products should eliminate guesswork for manufacturers while also giving the plaintiffs’ bar a more stationary target.
The FDA is required by 29 December under the Modernization of Cosmetics Regulation Act (MOCRA) to issue a proposed regulation...